Clinical Trials Browser

Phase 2/3 × Neoplasms × cabazitaxel × Clear all

NCT01668459 2018-12-04

CabB1

Phase 2/3 Completed

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Neoplasms